ArticlePloS one2022

How do multi-morbidity and polypharmacy affect general practice attendance and referral rates? A retrospective analysis of consultations.

Andrew O'Regan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.